Brett King MD

Brett King MD

Company: Yale University School of Medicine

Job title: Associate Professor, Dermatology

Seminars:

Balancing Benefit/Risk in the Dermatology Disease Space 11:15 am

Read more

day: Day Two

PANEL DISCUSSION: The JAK Class Black Box Warning: The Implications for the JAK Inhibitor Drug Development Landscape for Dermatology & Beyond 10:00 am

Read more

day: Day Two

Balancing Benefit/Risk in the Dermatology Disease Space 11:15 am

Considering whether the black box warning will stifle innovation across the JAK inhibitor class Correlating disease severity and quality of life with off-target effects of JAK inhibitors Rethinking how we define the black box warning to patientsRead more

day: Day Two

PANEL DISCUSSION: The JAK Class Black Box Warning: The Implications for the JAK Inhibitor Drug Development Landscape for Dermatology & Beyond 10:00 am

Cataloguing the implications across numerous disciplines the FDA issued JAK black box warning will have just as pharma was beginning to realise the potential the JAK/STAT pathway holds. Evaluating where the community sees the market potential for JAK inhibitors within the pharmaceutical industry despite the warning. Discussing ways in which companies may begin marketing their…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.